Clinical Trials Search
Use this page to search all trials that are open to enrollment for adult and pediatric patients. For more information on clinical trials at Sanford Health, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890; and Sioux Falls Clinical Research at (605) 328-1388. You can also learn more by visiting clinicaltrials.gov, which is a comprehensive national registry of all clinical trials.
Cancer
Ancillary Laboratory Protocol for Collecting Diagnostic Material on Patients Considered for ECOG Treatment Trials for Leukemia or Related Hematologic Disorders
| Study ID: | ECOG E3903 |
| Disease: | Ancillary, HEME (Hemetologic) |
| Stage: | N/A |
| Learn More |
Ancillary Laboratory Protocol for Collecting Diagnostic Material on Patients Considered for Studies of Multiple Myeloma and Other Plasma Cell Disorders
| Study ID: | ECOG E3A05 |
| Disease: | Multiple Myeloma |
| Stage: | N/A |
| Learn More |
A Randomized Phase III Study of Temozolomide and Short-Course Radiation versus Short-Course Radiation Alone in the Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients
| Study ID: | ACCRU CE.6 |
| Disease: | Brain and Nervous System |
| Stage: | Phase III |
| Learn More |
Phase III Trial of Post-Surgical Stereotactic Radiosurgery Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease
| Study ID: | CTSU N107C |
| Disease: | Brain and Nervous System |
| Stage: | Phase III |
| Learn More |
Phase III Study of Radiation Therapy with or without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
| Study ID: | ECOG E3F05 |
| Disease: | Brain and Nervous System |
| Stage: | Phase III |
| Learn More |
Phase I/Randomized Phase II Double Blind Study of Either Dasatinib or Placebo Combined with Bevacizumab in Recurrent Glioblastoma
| Study ID: | NCCTG N0872 |
| Disease: | Brain and Nervous System |
| Stage: | Phase I/II |
| Learn More |
THE BEACON STUDY (BREAST CANCER OUTCOMES WITH NKTR-102): A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 versus Treatment of Physician?s Choice (TPC) in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated with an Anthracycline, a Taxane,and Capecitabine
| Study ID: | ACCRU Nektar 11-PIR-11; BEACON |
| Disease: | |
| Stage: | Phase III |
| Learn More |
A Prospective, Randomized Multicenter, Multinational, Double-Blind Placebo Controlled Comparison of Chemotherapy Plus Trastuzumab and Placebo Given for a Total of One Year Versus Chemotherapy Plus Trastuzumab and Pertuzumab Given for a Total of One Year as Adjuvant Therapy in Patients with Operable HER2-Positive Primary Breast Cancer
| Study ID: | ACCRU BO25126 Aphinity |
| Disease: | Breast - Invasive |
| Stage: | Phase III |
| Learn More |
A Phase 2 Randomized, Double-blind, Placeb-Controlled, 2-Arm, Multi-Center Study Comparing Tivozanib Hydrochloride in Combination with Paclitaxel vs Placebo in Combination with Paclitaxel in the Treatment of Subjects with Locally Recurrent and/or Metastatic Triple Negative Breast Cancer
| Study ID: | AVEO AV-951-12-204 |
| Disease: | |
| Stage: | Phase II |
| Learn More |
Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
| Study ID: | ECOG E2108 |
| Disease: | Breast - Invasive |
| Stage: | Phase III |
| Learn More |
A Phase I Study of MK-2206 in Combination With Lapatinib in Refractory Solid Tumors Followed by Dose-expansion in Advanced HER2+ Breast Cancer
| Study ID: | NCI CO10904 |
| Disease: | |
| Stage: | Phase I |
| Learn More |
Urinary expression of ADAM12 as a tumor marker for breast cancer treatment response
| Study ID: | SH ADAM 12 |
| Disease: | Breast - Invasive |
| Stage: | N/A |
| Learn More |
Randomized Study to Prevent Lymphedema in Women Treated for Breast Cancer
| Study ID: | CTSU C70305 |
| Disease: | Breast - Invasive |
| Stage: | Unknown |
| Learn More |
Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients with Bone Metastases Starting Zoledronic Acid Treatment
| Study ID: | CTSU S0702 |
| Disease: | Cancer Control |
| Stage: | Unknown |
| Learn More |
Impact of Genomics and Exposures on Disparities in Breast Cancer Radiosensitivity
| Study ID: | CTSU WF 97609 |
| Disease: | Cancer Control |
| Stage: | N/A |
| Learn More |
Validation and Comparison of Biomarkers for the Early Detection of Colorectal Adenocarcinoma
| Study ID: | CTSU NCCTG GLNE 010 |
| Disease: | Colorectal |
| Stage: | N/A |
| Learn More |
Randomized Phase II Trial Of Pet Scan-Directed Combined Modality Therapy In Esophageal Cancer
| Study ID: | CTSU C80803 |
| Disease: | Esophagus |
| Stage: | Phase II |
| Learn More |
Phase II/III trial of Neoadjuvant FOLFOX, with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision
| Study ID: | CTSU N1048 |
| Disease: | Rectum |
| Stage: | Phase II/III |
| Learn More |
Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1 (Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric, or Gastroesophageal Junction (GEJ) Cancer
| Study ID: | CTSU S1201 |
| Disease: | Esophagus, GE Junction, Stomach |
| Stage: | Phase II |
| Learn More |
Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPORT) in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy
| Study ID: | CTSU R0534 |
| Disease: | Prostate |
| Stage: | Phase III |
| Learn More |
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
| Study ID: | CTSU R0924 |
| Disease: | Prostate |
| Stage: | Phase III |
| Learn More |
Randomized Phase II Trial of Sunitinib/Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features
| Study ID: | ECOG E1808 |
| Disease: | REN (Renal) |
| Stage: | Phase II |
| Learn More |
Phase 3, Randomized, Double-blind Trial of Pegylated Liposomal Doxorubicin (PLD) Plus AMG 386 or Placebo in Women With Recurrent Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers Following a Prior Platinum-Containing Regimen
| Study ID: | AMGEN 386 Study 20060517 |
| Disease: | Ovary/Fallopian Tube/Primary Peritoneal |
| Stage: | Phase III |
| Learn More |
A Randomized Phase II Study of NCI Supplied Cabozantinib (NSC #761968 IND #116059) Versus Weekly Paclitaxel (NSC #673089) In The Treatment Of Persistent Or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
| Study ID: | GOG 0186K |
| Disease: | Ovary/Fallopian Tube/Primary Peritoneal |
| Stage: | Phase II |
| Learn More |
Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (Or Gemcitabine) Alone or in Combination with Bevacizumab (NSC #704865, IND #113912) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Fallopian Tube and Peritoneal Primary Cancer
| Study ID: | GOG 0213 |
| Disease: | Ovary/Fallopian Tube/Primary Peritoneal |
| Stage: | Phase III |
| Learn More |
Can Diet and Physical Activity Modulate Ovarian or Primary Peritoneal Cancer Progression-Free Survival?
| Study ID: | GOG 0225 |
| Disease: | Ovary/Fallopian Tube/Primary Peritoneal |
| Stage: | N/A |
| Learn More |
Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma
| Study ID: | GOG 0258 |
| Disease: | Endometrial |
| Stage: | Phase III |
| Learn More |
Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer
| Study ID: | GOG 0273 |
| Disease: | Ovary/Fallopian Tube/Primary Peritoneal |
| Stage: | Unknown |
| Learn More |
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers (Amgen Protocl #20101129)
| Study ID: | GOG 3001 Amgen 386; 20101129 Trinova-3 |
| Disease: | Ovary/Fallopian Tube/Primary Peritoneal |
| Stage: | Phase III |
| Learn More |
Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cancer
| Study ID: | CTSU R0920 |
| Disease: | Head & Neck |
| Stage: | Phase III |
| Learn More |
Outcomes of Head and Neck Squamous Cell Carcinoma of Unknown Primary
| Study ID: | Head & Neck Unknown Primary |
| Disease: | |
| Stage: | Unknown |
| Learn More |
Phase II Study of DCA (dichloracetate) vs. placebo in Combination with Cisplatin and Definitive Radiation in Stage III-IV Squamous Cell Carcinoma of the Head and Neck
| Study ID: | SH DCA 2010 |
| Disease: | Head & Neck |
| Stage: | Phase II |
| Learn More |
Topical Superoxide Dismutase for the Treatment of Radiation Induced Fibrosis in the Head and Neck Cancer Patient
| Study ID: | SH SODERMIX® (SOD) Vs. Placebo |
| Disease: | |
| Stage: | N/A |
| Learn More |
Understanding and Improving Treatment of Head and Neck Cancer
| Study ID: | SH Understanding and Improving Treatment of Head and Neck Cancer |
| Disease: | |
| Stage: | N/A |
| Learn More |
Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer
| Study ID: | UofM TALC |
| Disease: | |
| Stage: | Unknown |
| Learn More |
Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL)
| Study ID: | CTSU S1001 |
| Disease: | NHL (Non-Hodgkins Lymphoma) |
| Stage: | Phase II |
| Learn More |
Intergroup Randomized PhaseII Four Arm Study In Patients >/= 60 with Previously Untreated Mantle Cell Lymphoma of Therapy with: Arm A=Rituximab+Bendamustine Followed by Rituximab Consolidation (RB->R); Arm B=Rituximab+Bendamustine+Bortezomib Followed by Rituximab Consolidation (RBV->R);Arm C=Rituximab+Bendamustine Followed by Lenalidomide+Rituximab Consolidation (RB->LR), or Arm D= Rituximab+Bendamustine+Bortezomib Followed by Lenalidomide and Rituximab Consolidation (RBV->LR).
| Study ID: | ECOG E1411 |
| Disease: | Hematologic, Other |
| Stage: | Phase II |
| Learn More |
3-Arm Randomized Phase II Trial of Bendamustine-Rituximab (BR) Followed by Rituximab vs. Bortezomib-BR (BVR) Followed by Rituximab vs BR Followed by Lenalidomide/Rituximab in High Risk Follicular Lymphoma
| Study ID: | ECOG E2408 |
| Disease: | NHL (Non-Hodgkins Lymphoma) |
| Stage: | Phase II |
| Learn More |
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age >/= 60 Years)
| Study ID: | ECOG E2906 |
| Disease: | AML (Acute Myelogenic Leukemia) |
| Stage: | Phase III |
| Learn More |
A Compassionate Use Open-Label Study of Anti IL-5 (Mepolizumab) Treatment in Subjects with Hypereosinophilic Syndrome
| Study ID: | GSK MHE104317 |
| Disease: | |
| Stage: | Unknown |
| Learn More |
A phase 2 Open-label Study of MEDI-551 and bendamustine vs Rituximab and Bendamustine in Adults with Relapsed or Refractory CLL
| Study ID: | Medimmune CD-ON-MEDI-551-1019 |
| Disease: | CCL |
| Stage: | N/A |
| Learn More |
A Randomized Phase II Trial of Erlotinib alone or in combination with Bevacizumab in Patients with Non-Small Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations
| Study ID: | ACCRU RC1126 |
| Disease: | Non-Small Cell Lung Cancer |
| Stage: | Phase II |
| Learn More |
A Randomized Phase II Trial of Erlotinib, Cabozantinib, or Erlotinib plus Cabozantinib as 2nd or 3rd Line Therapy in Patients with EGFR Wild-Type NSCLC
| Study ID: | ECOG E1512 |
| Disease: | Non-Small Cell Lung Cancer |
| Stage: | Phase II |
| Learn More |
Phase II Randomized Trial of Paclitaxel, Carboplatin, Bevacizumab with or without IMC-A12 in Patients with Advanced Non-Squamous, Non-Small Cell Lung Cancer
| Study ID: | ECOG E3508 |
| Disease: | Non-Small Cell Lung Cancer |
| Stage: | Phase II |
| Learn More |
A Phase 2 Study of MLN8237 in Advanced / Metastatic Sarcoma
| Study ID: | CTSU A091102 |
| Disease: | |
| Stage: | Phase II |
| Learn More |
The National Cancer Institute (NCI) Community Cancer Center Program Patient Reported Symptom Surveillance and Disparities Study
| Study ID: | NCCCP Patient Reported Symptom Surveillance and Disparities Study |
| Disease: | |
| Stage: | N/A |
| Learn More |
Determine the feasability of including newly recognized metrics to measure the efficacy of Patient Navigation
| Study ID: | SH ACS Navigation Study |
| Disease: | |
| Stage: | Unknown |
| Learn More |
Children's
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens
| Study ID: | COG ACNS02B3 |
| Disease: | CNS (Brain Tumors) |
| Stage: | Unknown |
| Learn More |
A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal (18.00 Gy) and Chemotherapy in Children With Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial
| Study ID: | COG ACNS0331 |
| Disease: | CNS (Brain Tumors), LTE (Late Effects), CCL |
| Stage: | Phase III |
| Learn More |
A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy 18.00 Gy and Chemotherapy In Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial
| Study ID: | COG ACNS0331 Fargo |
| Disease: | |
| Stage: | Phase III |
| Learn More |
Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients
| Study ID: | COG ACNS0332 |
| Disease: | CNS (Brain Tumors) |
| Stage: | Phase III |
| Learn More |
A Phase III randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children <36 Months Old with Intensive Induction Chemotherapy with Methotrexate Followed by consolidation with Stem Cell Rescue vs. The Same Therapy Without Methotrexate
| Study ID: | COG ACNS0334 |
| Disease: | CNS (Brain Tumors) |
| Stage: | Phase III |
| Learn More |
A Randomized Phase II/III Study of Vorinostat (IND# 71976) and Local Irradiation OR Temozolomide and Local Irradiation OR Bevacizumab and Local Irradiation Followed by Maintenance Bevacizumab (IND # 7921) and Temozolomide in Newly Diagnosed High Grade Glioma
| Study ID: | COG ACNS0822 |
| Disease: | CNS (Brain Tumors) |
| Stage: | Phase II/III |
| Learn More |
A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric
Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and
Optic Pathway Gliomas
| Study ID: | COG ACNS1022 |
| Disease: | CNS (Brain Tumors) |
| Stage: | Phase II |
| Learn More |
MPS VI Clinical Surveillance Program
| Study ID: | BioMarin MPS VI CSP |
| Disease: | Other |
| Stage: | Post Marketing |
| Learn More |
The Genetics and Neuroendocrinology of Short Statue International Study
| Study ID: | Lilly GeNeSIS B9R-EW-GDFC |
| Disease: | |
| Stage: | Post Marketing |
| Learn More |
A Global, Multi-Center, Long-Term, Observational Survey of Patients with Hunter Syndrome (Mucopolysaccharidosis II)
| Study ID: | Shire HOS (hunter) |
| Disease: | Other |
| Stage: | Unknown |
| Learn More |
Intensified Methotrexate, Nelarabine (Compound 506U78; IND #52611) and Augmented BFM Therapy for Children and Young Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) or T-cell Lymphoblastic Lymphoma
| Study ID: | COG AALL0434 |
| Disease: | ALL (Acute Lymphocytic Leukemia), NHL (Non-Hodgkins Lymphoma) |
| Stage: | Phase III |
| Learn More |
A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens
| Study ID: | COG AALL05B1 |
| Disease: | ALL (Acute Lymphocytic Leukemia) |
| Stage: | Unknown |
| Learn More |
A Phase III Study of Risk Directed Therapy for Infants With Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; IND#76431; NSC#617807)
| Study ID: | COG AALL0631 |
| Disease: | ALL (Acute Lymphocytic Leukemia) |
| Stage: | Phase III |
| Learn More |
A Phase II Pilot Trial of Bortezomib (PS-341, Velcade®, IND #58,443) in Combination With Intensive Re-Induction Therapy for Children With Relapsed Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)
| Study ID: | COG AALL07P1 |
| Disease: | ALL (Acute Lymphocytic Leukemia) |
| Stage: | Phase II |
| Learn More |
Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
| Study ID: | COG AALL08B1 |
| Disease: | ALL (Acute Lymphocytic Leukemia) |
| Stage: | Unknown |
| Learn More |
Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)
| Study ID: | COG AALL0932 |
| Disease: | ALL (Acute Lymphocytic Leukemia) |
| Stage: | Phase III |
| Learn More |
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
| Study ID: | COG AAML08B1 |
| Disease: | AML (Acute Myelogenic Leukemia) |
| Stage: | Unknown |
| Learn More |
A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
| Study ID: | COG ACCL0933 |
| Disease: | AML (Acute Myelogenic Leukemia), CCL |
| Stage: | Phase III |
| Learn More |
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
| Study ID: | COG ACCL0934 |
| Disease: | ALL (Acute Lymphocytic Leukemia), AML (Acute Myelogenic Leukemia), CCL |
| Stage: | Phase III |
| Learn More |
A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for
Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme
Replacement Therapy: A Harmonized Protocol Across Sponsors
| Study ID: | Seattle Childrens CFFC-OB-11 |
| Disease: | |
| Stage: | Unknown |
| Learn More |
Renal Tumors Classification, Biology, and Banking Study
| Study ID: | COG AREN03B2 |
| Disease: | REN (Renal) |
| Stage: | N/A |
| Learn More |
Renal Tumors Classification, Biology, and Banking Study
| Study ID: | COG AREN03B2 Fargo |
| Disease: | |
| Stage: | N/A |
| Learn More |
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
| Study ID: | COG AREN0532 |
| Disease: | REN (Renal) |
| Stage: | Phase III |
| Learn More |
National Wilm's Tumor Study Late Effects
| Study ID: | COG NWTSG (4941L) |
| Disease: | LTE (Late Effects), REN (Renal) |
| Stage: | Unknown |
| Learn More |
A Study of Neurocognitive Function in Children Treated for ALL
| Study ID: | COG AALL06N1 |
| Disease: | ALL (Acute Lymphocytic Leukemia) |
| Stage: | Unknown |
| Learn More |
Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized
Central Nervous System Germ Cell Tumors (CNS GCT)
| Study ID: | COG ACNS1123 |
| Disease: | CNS (Brain Tumors), GCT (Germ Cell Tumor) |
| Stage: | Phase II |
| Learn More |
Neuropsychological, Social, Emotional and Behavioral Outcomes in Children with Cancer
| Study ID: | COG ALTE07C1 |
| Disease: | CNS (Brain Tumors), LTE (Late Effects), CCL |
| Stage: | Unknown |
| Learn More |
Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloblative Therapy and Autologous Stem Cell Rescue
| Study ID: | COG ANBL0032 |
| Disease: | NBL (Neuroblastoma) |
| Stage: | Phase III |
| Learn More |
Neuroblastoma Biology Studies
| Study ID: | COG ANBL00B1 |
| Disease: | NBL (Neuroblastoma) |
| Stage: | Unknown |
| Learn More |
A Phase II Randomized Trial of Irinotecan/Temozolomide with Temsirolimus (NSC# 683864,
IND# 61010) or Chimeric 14.18 Antibody (ch14.18) (NSC# 623408, IND# 4308) in Children with Refractory, Relapsed or Progressive Neuroblastoma
| Study ID: | COG ANBL1221 |
| Disease: | NBL (Neuroblastoma) |
| Stage: | Phase II |
| Learn More |
Growth and Tolerance of Young Infants Fed Infant Formulas
| Study ID: | Abbott AL06 |
| Disease: | |
| Stage: | Unknown |
| Learn More |
A Phase IV Multicenter, Randomized, Open Label, Two-period Crossover Study in Patients with Cystic Fibrosis to Evaluate the Comparable Efficacy and Safety of Pulmozyme Delivered by the ERapid Nebulizer System
| Study ID: | Genentech ML28249 (IMPART) Pulmozyme eRapid Phase 4 |
| Disease: | |
| Stage: | Phase IV |
| Learn More |
A Phase 3, Randomized, Double-Blind,Placebo-Controlled, Parallel-Group Study to Evaluate the
Efficacy and Safety of Lumacaftor Alone and in Combination With Ivacaftor in Subjects Aged 12 Years and Older with Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
| Study ID: | Vertex VX12-809-104 |
| Disease: | |
| Stage: | Phase III |
| Learn More |
A Children's Oncology Group Protocol for COllecting and Banking Ewing Sacroma Specimens
| Study ID: | COG AEWS07B1 |
| Disease: | EWS (Ewing Sarcoma) |
| Stage: | Unknown |
| Learn More |
A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma.
| Study ID: | COG AEWS1031 |
| Disease: | EWS (Ewing Sarcoma) |
| Stage: | Phase III |
| Learn More |
A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens
| Study ID: | COG AOST06B1 |
| Disease: | OST (Osteosarcoma) |
| Stage: | Unknown |
| Learn More |
A Randomized Phase II Trial of Bevacizumab (IND #7921, Avastin) and
Temsirolimus (IND# 61010, Torisel) in Combination with Intravenous Vinorelbine and Cyclophosphamide in Patients with Recurrent/Refractory Rhabdomyosarcoma
| Study ID: | COG ARST0921 |
| Disease: | RST (Soft Tissue Sarcoma) |
| Stage: | Phase II |
| Learn More |
A COG Soft Tissue Sarcoma Biology and Banking Protocol
| Study ID: | COG IRSG D9902 |
| Disease: | RST (Soft Tissue Sarcoma) |
| Stage: | Unknown |
| Learn More |
Key Adverse Events after Childhood Cancer
| Study ID: | COG ALTE03N1 |
| Disease: | LTE (Late Effects) |
| Stage: | Unknown |
| Learn More |
Hodgkin Disease Banking Study
| Study ID: | COG AHOD04B1 |
| Disease: | HOD (Hodgkin Disease) |
| Stage: | Unknown |
| Learn More |
Umbrella Long-Term Follow-Up Protocol
| Study ID: | COG ALTE05N1 |
| Disease: | LTE (Late Effects) |
| Stage: | N/A |
| Learn More |
Diabetes/Thyroid
Glycemic Control in DM1 Adolescents: Moderate-Intensity Exercise in Hot and Cool Environments
| Study ID: | Bergeron 03-10-007 HEAT |
| Disease: | |
| Stage: | Unknown |
| Learn More |
Natural History Study of The Development of Type 1 Diabetes
| Study ID: | TrialNet TN-01 |
| Disease: | Pancreas |
| Stage: | Unknown |
| Learn More |
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
| Study ID: | TrialNet TN-07 |
| Disease: | Pancreas |
| Stage: | Unknown |
| Learn More |
Family Practice
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
| Study ID: | Takeda EXAMINE SYR-322-402 |
| Disease: | |
| Stage: | Phase IIIB |
| Learn More |
Genitourinary
The Comparison of Rates of Bacteriuria and Urinary Tract Infection in Men Who Have Been Treated with Foley Catheterization vs. Men Who Have Been Treated with a Spanner Prostatic Stent™
| Study ID: | SH Compare Infection Foley/Spanner |
| Disease: | Prostate |
| Stage: | Unknown |
| Learn More |
Heart
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is Used in Combination With Statin Therapy in Patients with Clinically Evident Cardiovascular Disease
| Study ID: | Amgen FOURIER 20110118 |
| Disease: | |
| Stage: | Phase III |
| Learn More |
A randomised, double-blind, parallel group, multicentre phase IIIb study to compare ticagrelor with clopidogrel treatment on the risk of cardiovascular death, myocardial infarction and ischaemic stroke in patients with established Peripheral Artery Disease (EUCLID – Examining Use of tiCagreLor In paD)
| Study ID: | AstraZeneca EUCLID D5135C00001 |
| Disease: | |
| Stage: | N/A |
| Learn More |
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
| Study ID: | NHLBI ISCHEMIA NCT01471522 |
| Disease: | |
| Stage: | N/A |
| Learn More |
SJM Quadripolar Post Approval Study. This is an FDA mandated Study on our recently approved Quadripolar System: Unify Quadra CRT-D and the Quartet Lead.
| Study ID: | St. Jude Quadripolar Pacing Post Approval |
| Disease: | |
| Stage: | Unknown |
| Learn More |
ROADMAP (pending additional information)
| Study ID: | Thoratec ROADMAP study |
| Disease: | |
| Stage: | N/A |
| Learn More |
JOSTENT Graft Master Coronary Stent Graft and Delivery System - A Humanitarian Use Device for use in the treatment of free perforations, defined as free contrast extravasations into the pericardium, in native vessels or saphenous vein bypass grafts greater than or equal to 2.75mm in diameter.
| Study ID: | Abbott JOSTENT GraftMaster |
| Disease: | Heart |
| Stage: | HDE |
| Learn More |
Product Performance Platform
| Study ID: | Medtronic PPP (with AAF integrated) |
| Disease: | |
| Stage: | Post Marketing |
| Learn More |
A randomized, double-blind, placebo-controlled, event-driven trial of quarterly subcutaneous canakinumab in the prevention of recurrent cardiovascular events among stable post-myocardial infarction patients with persistently elevated hsCRP
| Study ID: | Novartis CANTOS CACZ885M2301 |
| Disease: | |
| Stage: | Phase II |
| Learn More |
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Intercostal Nerve Block with Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy
| Study ID: | PACIRA 402-C-322 |
| Disease: | |
| Stage: | Phase III |
| Learn More |
Infectious Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of a Single Infusion of MK-6072 (Human Monoclonal Antibody to Clostridium difficile toxin B) and MK-3415A (Human Monoclonal Antibodies to Clostridium difficile toxin A and toxin B) in Patients Receiving Antibiotic Therapy for Clostridium difficile Infection
| Study ID: | Merck MODIFY II MK-3415A |
| Disease: | |
| Stage: | Phase III |
| Learn More |
Interventional Radiology
Cordis Inspiration
| Study ID: | Cordis Inspiration |
| Disease: | |
| Stage: | IDE |
| Learn More |
Stenting and Angioplasty with Protection in Patients at High-Risk for Endarterectomy – SAPPHIRE WW
| Study ID: | Cordis SAPPHIRE P06-3603 |
| Disease: | |
| Stage: | Post Marketing |
| Learn More |
ACE: An Aneurysm Coiling Efficiency Study of the Penumbra Coil 400 System
| Study ID: | Penumbra CLP 4492 ACE |
| Disease: | |
| Stage: | N/A |
| Learn More |
Neonatology
Bridging the Docosahexaenoic Acid (DHA) Gap: The Effects of Omega-3 Fatty Acid Supplementation in Premature Infants.
| Study ID: | SH DHA Premie Infants |
| Disease: | |
| Stage: | Unknown |
| Learn More |
Nephrology
Enterra HDE Therapy System
| Study ID: | Medtronic Enterra H990014 |
| Disease: | |
| Stage: | HDE |
| Learn More |
The study is for anemia in chronic kidney disease for ESA-naive patients, who are not on dialysis.
| Study ID: | Amgen START CKD 20110226 Aranesp |
| Disease: | |
| Stage: | N/A |
| Learn More |
Neurology
SH_Gene Discovery in Inherited Neurological Disease
| Study ID: | SH Gene Discovery in Inherited Neurological Disease |
| Disease: | |
| Stage: | Unknown |
| Learn More |
Investigating the neural mechanisms of working memory using transcranial magnetic stimulation and electroencephalographic recording in healthy subjects
| Study ID: | NDSU Jeff Johnson MRI Psychology Study |
| Disease: | |
| Stage: | N/A |
| Learn More |
TRANSITION: A two-year observational study to evaluate
the safety profile of fingolimod in patients with multiple
sclerosis who switch from natalizumab to fingolimod
| Study ID: | Novartis CFTY720D2405 TRANSITION |
| Disease: | |
| Stage: | N/A |
| Learn More |
Ophthalmology
Safety and Efficacy of the KXL System with Riboflavin 0.1% Ophthalmic Solution for Corneal Collagen Cross-Linking in Eyes with Keratoconus
| Study ID: | Avedro KXL-001 |
| Disease: | |
| Stage: | Unknown |
| Learn More |
A PROSPECTIVE, RANDOMIZED, SINGLE-MASKED, CONTROLLED, PARALLEL GROUPS, MULTICENTER CLINICAL INVESTIGATION
OF THE GLAUKOS® TRABECULAR MICRO-BYPASS STENT
MODEL GTS400 USING THE G2-M-IS INJECTOR SYSTEM IN CONJUNCTION WITH CATARACT SURGERY
| Study ID: | GC-008 |
| Disease: | |
| Stage: | Phase I |
| Learn More |
Clinical Evaluation of The Safety and Effectiveness of the VeriFlex
Anterior Chamber Phakic IOL for the Correction of Myopia
| Study ID: | VFLX-102-6820 |
| Disease: | |
| Stage: | Phase II |
| Learn More |
Vascular
Carotid Artery Stenting Outcomes in the Standard Risk Population
for Carotid Endarterectomy
| Study ID: | Abbott CANOPY 10-720 |
| Disease: | |
| Stage: | Post Marketing |
| Learn More |
Stenting and Angioplasty with Protection in Patients at High-Risk for Endarterectomy – SAPPHIRE WW
| Study ID: | Cordis SAPPHIRE P06-3603 |
| Disease: | |
| Stage: | Post Marketing |
| Learn More |
CREATE PAS Carotid Revascularization with ev3 Arterial Technology Evolution Post Approval Study
| Study ID: | ev3 CREATE PAS P-2611 |
| Disease: | |
| Stage: | Phase IV |
| Learn More |
The US StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem Post Approval Study (DURABILITY PAS)
| Study ID: | EV3 Durablilty PAS CP-1001 |
| Disease: | |
| Stage: | Post Marketing |
| Learn More |
Pythagoras: Prospective Aneurysm Trial: High Angle Aorfix™ bifurcated stent graft.
| Study ID: | Lombard PYTHAGORAS 2005-01 |
| Disease: | |
| Stage: | Unknown |
| Learn More |
Paclitaxel Reduces Effects of Intimal Hyperplasia Status Post Lower Extremity Revascularization
| Study ID: | SRUSD Paclitaxel |
| Disease: | |
| Stage: | Unknown |
| Learn More |
Retrospective review of management of vascular infections with biologic grafts
| Study ID: | VASC Biologic Grafts 03-12-020 |
| Disease: | |
| Stage: | N/A |
| Learn More |
Other
Targeting ACE2/Angiotension-(1-7)/Mas axis to enhance vasoreparative function of endothelial progenitor cells in diabetes
| Study ID: | NDSU Vasoreparative Function Study |
| Disease: | |
| Stage: | Unknown |
| Learn More |
The Sanford Health BioBank
| Study ID: | SH BioBank |
| Disease: | |
| Stage: | Unknown |
| Learn More |
A Randomized Double Blinded Controlled Trial of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients
| Study ID: | Abbott BL01 Nutrition Older Hospitalized |
| Disease: | |
| Stage: | Unknown |
| Learn More |
Genetic Studies of Reproductive Disorders
| Study ID: | Medical College of Georgia GEORGIA |
| Disease: | |
| Stage: | Unknown |
| Learn More |